Mathematical study of a staged-progression HIV model with imperfect vaccine

Bulletin of Mathematical Biology

Volumn 68, Issue 8, 2006, Pages 2105-2128

  Gumel, A B ^a   McCluskey, Connell C ^b   Van Den Driessche, P ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b WILFRID LAURIER UNIVERSITY   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Global stability; HIV AIDS; Staged progression; Vaccination reproduction number

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DISEASE COURSE; DISEASE TRANSMISSION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; COMPUTER SIMULATION; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, IMMUNOLOGICAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33750693054     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-006-9095-7     Document Type: Article

References (38)

1. Anderson, R.M., May, R.M., 1991. Infectious Diseases of Humans. Oxford University Press, London/New York.
2. Arino, J., McCluskey, C.C., van den Driessche, P., 2003. Global results for an epidemic model with vaccination that exhibits backward bifurcation. SIAM J. Appl. Math. 64, 260-276.
3. Baggeley, R.F., Ferguson, N.M., Garnett, G.P., 2005. The epidemiological impact of antiretroviral use predicted by mathematical models: A review. Emerg. Themes Epidemiol. 2, 9. (http://www.ete-online.com/contect/2/1/9). Accessed September 20, 2005.
4. Blower, S.M., McLean, A.R., 1994. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science 265, 1451-1454.
5. Brauer, F., Castillo-Chavez, C., 2000. Mathematical Models in Population Biology and Epidemiology. Texts in Applied Mathematics Series, vol. 40. Springer-Verlag, New York.
6. Burton, D.R., et al., 2004. A sound rationale needed for Phase III HIV-1 vaccine trials. Science 303, 316.
7. 0 and its role on global stability. In: Castillo-Chavez, C., with Blower, S., van den Driessche, P., Kirschner, D., Yakubu, A.-A. (Eds.), Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction. The IMA Volumes in Mathematics and its Applications, vol. 125. Springer, New York, pp. 229-250.
8. Chang, M.L., Vitek, C., Esparza, J., 2003. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002. AIDS 17, W1-10.
9. Corbett, B.D., Moghadas, S.M., Gumel, A.B., 2003. Subthreshold domain of bistable equilibria for a model of HIV epidemiology. IJMMS 58, 3679-3698.
10. Del Valle, S., Evangelista, A.M., Velasco, M.C., Kribs Zaleta, C.M., Schmitz, S.H., 2004. Effects of education, vaccination and treatment on HIV transmission in homosexuals with genetic heterogeneity. Math. Bios. 187, 111-133.
11. Elbasha, E.H., Gumel, A.B., 2006. Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits. Bull. Math. Biol. DOI 10.1007/s11538-005-9057-5.
12. Esparza, J., Osmanov, S., 2003. HIV vaccines: A global perspective. Curr. Mol. Med. 3, 183-193.
13. Fleck, F., 2004. Developing economies shrink as AIDS reduces workforce. BMJ 329, 129.
14. Gray, R., Li, X., Wawer, M., Gange, S., Serwadda, D., et al., 2003. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17, 1941-1951.
15. Hethcote, H.W., 1989. Three basic epidemiological models. In: Gross, L., Hallam, T.G., Levin, S.A. (Eds.), Applied Mathematical Ecology. Springer, Berlin, pp. 119-144.
16. Hethcote, H.W., 2000. The mathematics of infectious diseases. SIAM Rev. 42(4), 599-653.
17. Hyman, J.M., Li, J., Stanley, E.A., 1999. The differential infectivity and staged progression models for the transmission of HIV. Math. Biosci. 208, 227-249.
18. Klausner, R.D., et al., 2003. The need for a global HIV vaccine enterprise. Science 300, 2036-2039.
19. Kribs-Zaleta, C., Velasco-Hernández, J., 2000. A simple vaccination model with multiple endemic states. Math. Biosci. 164, 183-201.
20. Lakshmikantham, V., Leela, S., Martynyuk, A.A., 1989. Stability Analysis of Nonlinear Systems. Marcel Dekker, Inc., New York and Basel.
21. Lansky, A., Nakashima, A., Jones, J., 2000. Risk behaviors related to heterosexual transmission from HIV-infected persons. Sex. Transm. Dis. 27, 483-489.
22. Lee, D., et al., 2004. Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. J. Infect. Dis. 190(5), 903-907.
23. Li, M.Y., Muldowney, J.S., 1995. On R.A. Smith's autonomous convergence theorem. Rocky Mount. J. Math. 25, 365-379.
24. Li, M.Y., Muldowney, J.S., 1996. A geometric approach to global-stability problems. SIAM J. Math. Anal. 21, 1070-1083.
25. McCluskey, C.C., 2003. A Model for HIV/AIDS with staged progression and amelioration. Math. Bios. 181, 1-16.
26. McCluskey, C.C., 2005. A strategy for constructing Lyapunov functions for non-autonomous linear differential equations. Linear Algebra Appl. 409, 100-110.
27. McLean, A.R., Blower, S.M., 1993. Imperfect vaccines and herd immunity to HIV. Proc. R. Soc. Lond. Series B 253, 9-13.
28. Nicolosi, A., Musicco, M., Saracco, A., Lazzarin, A., 1994. Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. J. Acq. Immun. Def. Synd. 7, 296-300.
29. O'Brien, T., Busch, M., Donegan, E., Ward, J., Wong, L., et al., 1994. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J. Acquir. Immune. Defic. Syndr. 7, 705-710.
30. Perelson, A., Nelson, P., 1999. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41, 3-44.
31. Shiver, J., Emini, E., 2004. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Ann. Rev. Med. 55, 355-372.
32. Shiver, J., Fu, T.-M., Chen, L., Casimiro, D., Davies, M.-A., et al., 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331-335.
33. Smith, R.J., Blower, S.M., 2004. Could disease-modifying HIV vaccines cause population-level pervasity? Lancet Infec. Dis. 4, 636-639.
34. Smith, H.L., Waltman, P., 1995. The Theory of the Chemostat. Cambridge University Press.
35. van den Driessche, P., Watmough, J., 2002. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Bios. 180, 29-48.
36. World Bank, 1997. Confronting AIDS: Public Priorities in a Global Epidemic. Oxford University Press, Oxford.
37. WHO, 2004. The World Health Report: Changing History. World Health Organization, 1211 Geneva 27, Switzerland.
38. Zinkernagel, R.M., 2004. The challenges of an HIV vaccine enterprise. Science 303, 1294-1297.